Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular components that functionally interact with signaling phospholipase A(2)s.

M Murakami1, Y Nakatani, H Kuwata

  • 1Department of Health Chemistry, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, 142-8555, Tokyo, Japan.

Biochimica Et Biophysica Acta
|November 18, 2000
PubMed
Summary

Cytosolic and secretory phospholipase A2 (PLA2) enzymes release arachidonic acid (AA) for prostaglandin synthesis, interacting with cyclooxygenase enzymes. Specific PLA2 isozymes utilize unique mechanisms and cofactors for AA release, influencing prostaglandin production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.

Bone reports·2017
Same author

Nucleases from Prevotella intermedia can degrade neutrophil extracellular traps.

Molecular oral microbiology·2016
Same author

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs.

Diabetes, obesity & metabolism·2014
Same author

Effect of highly lipolyzed goat cheese on HL-60 human leukemia cells: antiproliferative activity and induction of apoptotic DNA damage.

Journal of dairy science·2012
Same author

Study on the General Anesthesia of Dental Out-patients in Japan: with Particular Reference to Fluothane Nitrous Oxide and Oxygen Anesthesia.

Journal of the American Dental Society of Anesthesiology·2009
Same author

Expression of type V secretory phospholipase A in myocardial remodelling after infarction.

Histopathology·2005

Area of Science:

  • Biochemistry
  • Cell Biology
  • Enzymology

Background:

  • Cytosolic phospholipase A2 (cPLA2) and secretory phospholipase A2 (sPLA2) isozymes are key signaling enzymes involved in prostaglandin (PG) biosynthesis.
  • Arachidonic acid (AA), released by these PLA2s, serves as a substrate for cyclooxygenase (COX) enzymes, primarily COX-2, in PG production.
  • Cellular components like vimentin and glypican act as adapters and sorting factors for specific PLA2 isozymes, influencing their localization and function.

Purpose of the Study:

  • To elucidate the intricate mechanisms by which cytosolic and secretory phospholipase A2 enzymes release arachidonic acid for prostaglandin biosynthesis.
  • To investigate the roles of cellular cofactors, membrane interactions, and specific isozyme properties in regulating PLA2 activity.
  • To understand the functional cooperation between different PLA2 isozymes and their downstream signaling pathways.

Related Experiment Videos

Main Methods:

  • Analysis of enzyme kinetics and substrate specificity for various PLA2 isozymes.
  • Investigation of protein-protein interactions using techniques like co-immunoprecipitation.
  • Cell-based assays to study arachidonic acid release and prostaglandin production.
  • Localization studies using immunofluorescence microscopy.

Main Results:

  • cPLA2 and sPLA2s are functionally coupled to COX isozymes for PG synthesis, with AA supplied to both COX-1 and COX-2.
  • Vimentin serves as a perinuclear adapter for cPLA2, while glypican sorts heparin-binding sPLA2s to specific cellular compartments.
  • Phospholipid scramblase enhances membrane susceptibility to signaling sPLA2s, and functional cooperation exists between cPLA2 and sPLA2s.
  • sPLA2-X and sPLA2-V can release AA from intact cells via hydrolysis of phosphatidylcholine, independent of cofactors in some cases.

Conclusions:

  • The AA-releasing function of sPLA2s is highly dependent on regulatory cofactors and specific interfacial binding to membrane phospholipids.
  • Cell type, stimuli, secretory processes, and subcellular localization dictate the distinct mechanisms employed by sPLA2s for AA release.
  • Understanding these complex regulatory networks is crucial for comprehending prostaglandin-mediated signaling pathways.